Publications by authors named "R Bellmann-Weiler"

Coronavirus Disease 2019 causes significant morbidity, and different variants of concern (VOCs) can impact organ systems differently. We conducted a single-center retrospective cohort analysis comparing biomarkers and clinical outcomes in hospitalized patients infected with the wild-type or Alpha (wt/Alpha) VOC against patients infected with the Omicron VOC. We included 428 patients infected with the wt/Alpha VOC and 117 patients infected with the Omicron VOC.

View Article and Find Full Text PDF
Article Synopsis
  • Pneumonia, caused by viruses and bacteria, triggers both innate and adaptive immune responses, which can be measured through biomarkers like C-reactive protein (CRP) and Neopterin.
  • A study involving 194 patients aimed to evaluate these biomarkers in differentiating between viral and bacterial pneumonia and to assess the occurrence of neuropsychiatric symptoms among patients.
  • Results indicated that higher CRP/Neopterin ratios are linked to bacterial pneumonia, while lower ratios were found in COVID-19 and bacterial superinfections, successfully distinguishing between the types of pneumonia and indicating the presence of superinfections.
View Article and Find Full Text PDF

Research into the molecular basis of disease trajectory and Long-COVID is important to get insights toward underlying pathophysiological processes. The objective of this study was to investigate inflammation-mediated changes of metabolism in patients with acute COVID-19 infection and throughout a one-year follow up period. The study enrolled 34 patients with moderate to severe COVID-19 infection admitted to the University Clinic of Innsbruck in early 2020.

View Article and Find Full Text PDF
Article Synopsis
  • Seasonally circulating viruses, like Influenza and SARS-CoV-2 variants, highlight the need for affordable and effective antiviral medications.
  • The study tested a natural essence called P80, derived from Dimocarpus longan, and found it effectively protected human airway cells from these viruses while reducing inflammation.
  • P80 can be used as a nasal spray or lozenge, showing promise as a preventive treatment against respiratory infections, with lasting protective effects on tissue integrity and immune response.
View Article and Find Full Text PDF

Purpose: Olfactory dysfunction (OD) commonly accompanies coronavirus disease 2019 (COVID-19). We investigated the kinetics of OD resolution following SARS-CoV-2 infection (wild-type and alpha variant) and its impact on quality of life, physical and mental health.

Methods: OD prevalence was assessed in an ambulatory COVID-19 survey (n = 906, ≥ 90 days follow-up) and an observational cohort of ambulatory and hospitalized individuals (n = 108, 360 days follow-up).

View Article and Find Full Text PDF